Skip to main content
$43.73 -$0.40 (-0.9%)

04:00 PM EDT on 07/30/21

Sage Therapeutics, Inc. (NASDAQ:SAGE)

CAPS Rating: 3 out of 5

Current Price $43.73 Mkt Cap $2.6B
Open $43.80 P/E Ratio 3.68
Prev. Close $43.73 Div. (Yield) $0.00 (0.0%)
Daily Range $43.67 - $44.93 Volume 888,959
52-Wk Range $42.85 - $98.39 Avg. Daily Vol. 1,088,027

Caps

How do you think NASDAQ:SAGE will perform against the market?

Add Stock to CAPS Watchlist

All Players

44 Outperform
6 Underperform
 

All-Star Players

13 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SAGE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

GNUBEE (< 20)
Submitted November 10, 2014

fist pick in a few years, following Porte to get my feet wet...

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:SAGE VS S&P 500 (SPY)

NASDAQ:SAGE Summary

Fools bullish on NASDAQ:SAGE are also bullish on:

Fools bearish on NASDAQ:SAGE are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SAGE.

Recs

0
Member Avatar ak1010 (99.93) Submitted: 7/6/2020 5:16:28 PM : Outperform Start Price: $64.99 NASDAQ:SAGE Score: -72.42

?

Recs

0
Member Avatar XMFRendezvous (97.90) Submitted: 2/9/2018 3:08:16 AM : Outperform Start Price: $159.02 NASDAQ:SAGE Score: -140.65

Sage Therapeutics has had an incredible few months as the FDA has fast tracked some of their treatments. Sage business seems to be catching some headwinds and they are looking to offer more stock to continue to fuel their business. Many of their drugs have to do with mental disorders such a depression, and where I do question the merits of drugs for mental illness I acknowledge the science behind it and unfortunately I do think that mental health will only continue to be more of an issue in the future.

I always have trouble writing about Biotechs because I really don't know what I am taking about but, many biotech analysts are high on this stock. Sage looks to be like one of the top programmers.

Recs

0
Member Avatar TMFGBudwell (68.43) Submitted: 12/7/2017 5:33:35 PM : Outperform Start Price: $158.97 NASDAQ:SAGE Score: -137.98

Multiple product candidates in development.

Leaderboard

Find the members with the highest scoring picks in SAGE.

Score Leader

BeatdaMarket

BeatdaMarket (52.49) Score: +160.45

The Score Leader is the player with the highest score across all their picks in SAGE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
WildShaman 81.37 7/9/2018 Underperform 5Y $160.36 -72.73% +58.58% +131.31 0 Comment
zzlangerhans 98.68 9/11/2017 Underperform 1Y $88.32 -50.49% +76.80% +127.29 0 Comment
FunesDMemorious 27.80 3/23/2016 Underperform 5Y $28.09 +55.68% +115.08% +59.40 0 Comment
DyingClub < 20 8/3/2020 Underperform 5Y $46.09 -5.12% +33.57% +38.69 0 Comment
NorteClub 32.91 6/11/2020 Underperform 5Y $36.38 +20.20% +40.85% +20.65 0 Comment
Bigcaps19 30.89 6/8/2020 Underperform 5Y $36.15 +20.97% +36.92% +15.95 0 Comment
drugtrader 85.68 4/16/2020 Outperform 5Y $26.90 +62.57% +57.10% +5.46 0 Comment
PandaTears 24.10 7/26/2021 Outperform 5Y $44.99 -2.80% -0.18% -2.63 0 Comment
IMGNE 38.42 7/15/2021 Outperform 5Y $48.23 -9.33% +1.08% -10.41 0 Comment
XMFmoatster 99.46 7/9/2021 Outperform 5Y $53.48 -18.23% +1.39% -19.62 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SAGE.